NuVasive Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and NuVasive are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days NuVasive has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NuVasive is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 247.6 M | |
| Total Cashflows From Investing Activities | -155.2 M |
NuVasive |
NuVasive Relative Risk vs. Return Landscape
If you would invest (100.00) in NuVasive on November 18, 2024 and sell it today you would earn a total of 100.00 from holding NuVasive or generate -100.0% return on investment over 90 days. NuVasive is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than NuVasive, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NuVasive Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NuVasive's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NuVasive, and traders can use it to determine the average amount a NuVasive's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NUVA |
Based on monthly moving average NuVasive is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NuVasive by adding NuVasive to a well-diversified portfolio.
NuVasive Fundamentals Growth
NuVasive Stock prices reflect investors' perceptions of the future prospects and financial health of NuVasive, and NuVasive fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NuVasive Stock performance.
| Return On Equity | 0.0331 | |||
| Return On Asset | 0.0242 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 2.91 B | |||
| Shares Outstanding | 52.45 M | |||
| Price To Earning | 51.79 X | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 1.79 X | |||
| Revenue | 1.2 B | |||
| EBITDA | 211.8 M | |||
| Cash And Equivalents | 225.98 M | |||
| Cash Per Share | 4.34 X | |||
| Total Debt | 1.01 B | |||
| Debt To Equity | 1.22 % | |||
| Book Value Per Share | 17.02 X | |||
| Cash Flow From Operations | 169.12 M | |||
| Earnings Per Share | 0.53 X | |||
| Total Asset | 2.22 B | |||
| Retained Earnings | 86.11 M | |||
| Current Asset | 702.83 M | |||
| Current Liabilities | 99.62 M | |||
Things to note about NuVasive performance evaluation
Checking the ongoing alerts about NuVasive for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NuVasive help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NuVasive is not yet fully synchronised with the market data | |
| NuVasive has some characteristics of a very speculative penny stock | |
| NuVasive has a very high chance of going through financial distress in the upcoming years | |
| Over 100.0% of the company shares are owned by institutional investors |
- Analyzing NuVasive's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NuVasive's stock is overvalued or undervalued compared to its peers.
- Examining NuVasive's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NuVasive's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NuVasive's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NuVasive's stock. These opinions can provide insight into NuVasive's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |